Email This Article
Headlines & Perspectives
Higher Revenue Per Patient Helps Bio-Reference
By
TSC Ratings
06/05/09 - 03:09 PM EDT
The lab company's revenues surged in the second quarter, helping boost earnings.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,456.46 | 1,110.39 | 2,194.96 | 33.67 |
Oil *
78.45
|
|
UP
3.78
|
UP
1.15
|
UP
9.93
|
UP
0.44
|
10 Yr
3.37%
SPDR Gold
118.93
|
|
+0.04%
|
+0.10%
|
+0.45%
|
+1.32%
|
Data delayed 20 minutes |


Connect with TheStreet